Dyskerin gene is mutated in patients with X-linked dyskeratosis congenita (X-DC), which results in greatly reduced levels of telomerase activity. A genetic suppressor element (GSE) termed GSE24-2 has been isolated in a screening for cisplatin resistance. GSE24-2-expressing cells presented impaired telomerase inhibition following in vitro exposure to chemotherapies, such as cisplatin, or telomerase inhibitors. The promoter of the telomerase component hTERT was constitutively activated in GSE24-2 cells in a c-myc expression-dependent manner. Deletion analyses and mutagenesis of the human c-myc promoter demonstrated that the target sequence for activation was the nuclease hypersensitive element-III (NHEIII) site located upstream to the P1 region of the promoter. Further, expression of GSE24-2 in cell lines derived from patients with X-DC and in VA13 cells induced increased hTERT RNA and hTR levels and recovery of telomerase activity. Finally, expression of GSE24-2 was able to rescue X-DC fibroblasts from premature senescence. These data demonstrate that this domain of dyskerin plays an important role in telomerase maintenance following cell insults such as cisplatin treatment, and in telomerase
IntroductionTelomeres consist of TTAGGG repeats, 1 which shorten in each cell cycle due to the inability of DNA polymerases to replicate the ends of linear DNA molecules. This telomere erosion is counteracted by telomerase, a protein-RNA molecule that mediates the synthesis of the telomeric repeats from a template encoded by telomere RNA (TR). 2,3 Telomere shortening, or loss of secondary structure, causes cells to enter senescence and/or apoptosis. These 2 processes act as biologic checkpoints to prevent uncontrolled cell division and genetic instability. 4,5 Defects in telomere length have been implicated in the pathology of several diseases, such as premature aging syndromes and cancer. 6 Active telomerase complexes comprise hTERT, hTR, and Dyskerin. 7 Telomerase expression is repressed in most postnatal somatic cells but is maintained in the majority of human cancers, thus contributing to the immortal phenotype by ensuring telomere integrity. 6 Telomerase activity is regulated, mainly, at hTERT transcription level 8 and, in humans, is controlled by a 5Ј regulatory region of the hTERT gene, which is required for maximal activity and contains a myc binding site (E-box). 8,9 c-MYC transcription factor stimulates hTERT expression, whereas enforced expression of mad1 represses hTERT. 10,11 Transcriptional regulation of c-myc involves multiple promoters, the predominant ones being P1 and P2. 12 The nuclease hypersensitive element-III (NHEIII) of the c-MYC promoter controls 85% to 90% of c-MYC transcription and was originally identified as a major DNAseI hypersensitivity site. 13 NHEIII contains a purine-rich encoding strand capable of establishing an equilibrium between a duplexhelix structure and non-B-forms of DNA. 14 The DNA-purine-rich strand can form 2 different intramolecular G-quadruplex structures, 15 which, since the...